Connect with us

Life Sciences

StartUp Health Insights: scan.com Closes £2.2M to Make Diagnostic Imaging Accessible to All

StartUp Health Insights: scan.com Closes £2.2M to Make Diagnostic Imaging Accessible to All | Week of Sep 13, 2022StartUp Health portfolio company scan.com aims to dramatically speed up the process of booking and receiving results for medical imaging s…

Published

on

This article was originally published by Stories by StartUp Health on Medium

StartUp Health Insights: scan.com Closes £2.2M to Make Diagnostic Imaging Accessible to All | Week of Sep 13, 2022

StartUp Health portfolio company scan.com aims to dramatically speed up the process of booking and receiving results for medical imaging scans. The London-based company plans to use the new funds to expand its diagnostics-as-a-service offering in the US and Germany and rapidly scale its B2B platform in the UK.

Investors, learn how you can back Health Transformers like the scan.com team through the StartUp Health Moonshots Impact Fund.

Our team tracked more than $400M in health innovation funding reported this week, including £2.2M ($2.5M) for StartUp Health portfolio company scan.com, a London, UK-based digital platform for booking and receiving medical scan results. The round was led by Triple Point Ventures, with participation from StartUp Health, Plug and Play Ventures, and YZR Capital. <source>

Other recent deals included:

Nimbus Therapeutics, a Cambridge, MA-based drug discovery company using computational technologies and machine learning-based predictive modeling approaches, raised $125M from Bain Capital Life Sciences, SV Health Investors, Access Biotechnology, Atlas Venture, BVF Partners, Bill Gates, Lightstone Ventures, Pfizer Ventures, RA Capital Management, and SR One. <source>

Forge Biologics, a Columbus, OH-based provider of a gene therapy-focused contract development and manufacturing organization, raised $90M led by Drive Capital and Aisling Capital. <source>

Elephas, a Madison, WI-based oncology diagnostics platform, raised $41.5M led by ARCH Venture Partners, with participation from Moore Strategic Ventures, Tao Capital Partners,y Northpond Ventures, Sands Capital, and WARF Ventures. <source>

PurpleLab, a Wayne, PA-based health tech company providing a no-code analytics platform, raised $40M led by Primus Capital, with participation from Edison Partners. <source>

LetsGetChecked, a Dublin, Ireland-based home diagnostics startup, raised $20M from Casdin Capital, Transformation Capital, and Morgan Health. <source>

Otolith, a Washington, DC-based medtech company developing noninvasive wearable devices for the treatment of vestibular disorders, raised $20M from Morningside Ventures. <source>

InsideTracker, a Boston, MA-based healthspan optimization platform, raised $15M led by PeakBridge, with participation from Cornucopian Capital, OurCrowd, BASF Venture Capital, and existing investors. <source>

CertifyOS, a New York, NY-based provider intelligence platform, raised $14.5M led by General Catalyst, with participation from Upfront Ventures, Max Ventures, and Arkitekt Ventures. <source>

Upfront Healthcare Services, a Chicago, IL-based communication and patient engagement platform, raised $10M co-led by Baird Capital, Echo Health Ventures, and First Trust Capital Partners, with participation from LRVHealth, Hyde Park Venture Partners, and Nashville Capital Network. <source>

HealthMatch, a Surry Hills, Australia-based clinical trial platform, raised A$10M ($6.8M) led by Folklore Ventures, with participation from Square Peg Capital and others. <source>

Dyania Health, an Athens, Greece- and Los Angeles, CA-based clinical research startup, raised $5M led by Innospark Ventures, with participation from Outsiders Fund, Wild Basin, and Big Pi.

Millie, a Berkeley, CA-based tech-enabled maternity clinic, raised $4M led by TMV Ventures and BBG Ventures, with participation from Venn Growth Partners, Looking Glass Capital, Learn Capital, Hustle Fund, and others. <source>

Trek Health, a San Mateo, CA-based payment and insurance workflow automation platform for mental health provider groups, raised $2.7M led by Lionheart Ventures, with participation from Founder Collective, Altman Capital, Ford Street Ventures, and others. <source>

Evrima, a Sydney, Australia-based clinical trial technology startup, raised A$3M ($2M) from Artesian. <source>

Data is from StartUp Health Insights, the most comprehensive funding database for health innovation. Get all our free quarterly reports and sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

Passionate about Type 1 diabetes? If you’re an entrepreneur or investor, contact us to learn how you can join our T1D Moonshot.

Investors: Learn how you can invest in Health Moonshots through StartUp Health’s impact fund.

Digital health entrepreneur? Don’t make the journey alone. Learn more about the StartUp Health Community and how StartUp Health invests.

Follow us on social media for daily updates on Health Transformers: Twitter, LinkedIn, Facebook, and Instagram.


StartUp Health Insights: scan.com Closes £2.2M to Make Diagnostic Imaging Accessible to All was originally published in StartUp Health on Medium, where people are continuing the conversation by highlighting and responding to this story.

manufacturing
diagnostics
therapeutics
gene therapy
biologics
medical
life sciences
healthcare
imaging
diagnostic
health
devices
digital health
machine learning
venture capital
fund

Markets

Wittiest stocks:: Avalo Therapeutics Inc (NASDAQ:AVTX 0.00%), Nokia Corp ADR (NYSE:NOK 0.90%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Spellbinding stocks: LumiraDx Limited (NASDAQ:LMDX 4.62%), Transocean Ltd (NYSE:RIG -2.67%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner

The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….

Continue Reading

Trending